Identification and Evaluation of Reversible Covalent Binders to Cys55 of Bfl-1 from a DNA-Encoded Chemical Library Screen
- 20 May 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 15 (6) , 791-797
Abstract
Bfl-1 is overexpressed in both hematological and solid tumors; therefore, inhibitors of Bfl-1 are highly desirable. A DNA-encoded chemical library (DEL) screen against Bfl-1 identified the first known reversible covalent small-molecule ligand for Bfl-1. The binding was validated through biophysical and biochemical techniques, which confirmed the reversible covalent mechanism of action and pointed to binding through Cys55. This represented the first identification of a cyano-acrylamide reversible covalent compound from a DEL screen and highlights further opportunities for covalent drug discovery through DEL screening. A 10-fold improvement in potency was achieved through a systematic SAR exploration of the hit. The more potent analogue compound 13 was successfully cocrystallized in Bfl-1, revealing the binding mode and providing further evidence of a covalent interaction with Cys55.Keywords
This publication has 42 references indexed in Scilit:
- Covalent hits and where to find themSLAS Discovery, 2024
- Discovery of a selective and covalent small-molecule inhibitor of BFL-1 protein that induces robust apoptosis in cancer cellsEuropean Journal of Medicinal Chemistry, 2022
- Novel irreversible covalent BTK inhibitors discovered using DNA-encoded chemistryBioorganic & Medicinal Chemistry, 2021
- Scanning Protein Surfaces with DNA‐Encoded LibrariesChemMedChem, 2020
- Selective Covalent Targeting of Anti‐apoptotic BFL‐1 by a Sulfonium‐Tethered PeptideChemBioChem, 2020
- Identification of a Covalent Molecular Inhibitor of Anti-apoptotic BFL-1 by Disulfide TetheringCell Chemical Biology, 2020
- Selective Covalent Targeting of Anti-Apoptotic BFL-1 by Cysteine-Reactive Stapled Peptide InhibitorsCell Chemical Biology, 2016
- Structure-based design and synthesis of covalent-reversible inhibitors to overcome drug resistance in EGFRBioorganic & Medicinal Chemistry, 2015
- Completing the family portrait of the anti‐apoptotic Bcl‐2 proteins: Crystal structure of human Bfl‐1 in complex with BimFEBS Letters, 2008
- Differential Targeting of Prosurvival Bcl-2 Proteins by Their BH3-Only Ligands Allows Complementary Apoptotic FunctionMolecular Cell, 2005